Asher Holzer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Urogen Pharma (URGN – Research Report), with a p...

Goldman Sachs analyst Paul Choi maintained a Hold rating on Urogen Pharma (URGN – Research Report) on August 10 and set a price target of ...

ARK Investment Management LLC raised its position in UroGen Pharma Ltd. (NASDAQ:URGN – Get Rating) by 37.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 270,746 shares of the company’s stock after acquiring an additional 73,808 shares during […]

Globeflex Capital L P purchased a new stake in shares of UroGen Pharma Ltd. (NASDAQ:URGN – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,279 shares of the company’s stock, valued at approximately $127,000. Globeflex Capital L P […]

Opaleye Management Inc. boosted its position in UroGen Pharma Ltd. (NASDAQ:URGN – Get Rating) by 22.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 488,656 shares of the company’s stock after acquiring an additional 91,156 shares during the period. UroGen Pharma […]